CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
2016
|
|
Collaborative Acute Toxicity Modeling Suite (CATMoS)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NCATS
|
2018
|
|
Combined Exposures and Mixtures Research Program
|
Research Initiative
|
ATSDR, CDC, FDA, OASH
|
NIEHS
|
|
|
Full-text health-related documents at NLM (includes HSTAT) Bookshelf/Digital Repository
|
Resource Development
|
AHRQ, ATSDR, CDC, CMS, FDA, SAMHSA
|
|
1994
|
|
HHS Data Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASFR, ASPA, ASPE, ASPR, ATSDR, CDC, CMS, FDA, GDM, HRSA, IHS, ONC, OMHA
|
NLM, NIGMS, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ SGMRO
|
1996
|
|
HHS LGBT Policies Coordinating Committee (HHS LGBT CC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIMH, OD/ DPCPSI/ SGMRO
|
2011
|
|
HHS Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPE, ASFR, CDC, CMS, FDA, HRSA, IHS, ONC, IOS, ATSDR, SAMHSA
|
NICHD, OD/ DPCPSI/ ORWH, NHLBI
|
|
|
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
ICCVAM Read Across Workgroup (RAWG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
InterAgency Board (IAB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
NIEHS
|
2010
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NICHD, NIDCD, NIMH, NINDS
|
1988
|
|
Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, ASPE, ASPR, ATSDR, CDC, CMS, HRSA, IHS, SAMHSA
|
NIMH, NIDA, NICHD
|
1996
|
|
Interagency Coordinating Committee on the Validation of Alternative Toxicological Methods (ICCVAM)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA, CDC
|
NCI, OD, NLM
|
2003
|
|
Interagency Group on SARS-CoV-2 Evolution and Vaccine Cadence
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
LGBT Healthy People 2030 Working Group (LGBT HP 2030)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, OD/ DPCPSI/ SGMRO
|
2019
|
|
National Amyotrophic Lateral Sclerosis Registry (National ALS Registry)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NINDS
|
2011
|
|
National Emerging Contaminant Research Initiative
|
Research Initiative
|
CDC, ATSDR, FDA
|
|
|
|
National Response Team (NRT)
|
Committee, Advisory Group, or Work Group
|
ASPR, ATSDR, CDC
|
NIEHS
|
2003
|
|
National Toxicology Program Executive Committee (NTP EC)
|
Meeting/ Workshop
|
ATSDR, CDC, FDA, OASH
|
|
1978
|
|
Novel Tools and Approaches Research Program
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|
PCC Technical Working Group on PFAS
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
|
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children (PTFCEH)
|
Committee, Advisory Group, or Work Group
|
ACF, ASPR, CDC, ATSDR, FDA, OASH, SAMHSA
|
NICHD, NHLBI, NIMH, NIMHD
|
|
|
Research Operations Supporting the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|
SUDV Medical Countermeasures Acceleration Meeting
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
OD/ OSP
|
2001
|
|
|